Core Insights - CorVel Corporation's Executive Vice President Sarah Scott has been recognized in Business Insurance's "Women to Watch" list for 2025, celebrating her leadership and innovation in the insurance and risk management sectors [1][4]. Company Overview - CorVel Corporation has a 26-year history with Sarah Scott, who has significantly contributed to the company's product innovation, clinical integration, and digital transformation initiatives [2]. - The company utilizes technology such as artificial intelligence, machine learning, and natural language processing to manage healthcare costs and improve care episodes [5]. Leadership and Innovation - Sarah Scott's background as a registered nurse has informed her approach to enhancing patient outcomes and operational efficiency through a data-driven strategy [3]. - She is currently leading efforts to integrate generative AI into CorVel's product offerings, aiming to improve decision-making processes and outcomes for injured workers [3]. Team and Market Position - Scott's leadership style emphasizes value addition and performance, inspiring her teams to innovate and execute effectively, thereby strengthening CorVel's market position [4]. - The recognition of Scott is seen as a reflection of the collaborative efforts of her team in advancing the industry through technology that maintains the human connection in recovery [4].

Core Insights - CorVel Corporation has been recognized in TIME's America's Growth Leaders 2026 Ranking, highlighting its exceptional growth performance, financial stability, and stock performance [1][2] - The company is the only one in its industry to receive this recognition, emphasizing its leadership, innovation, and commitment to delivering value to partners and shareholders [2] Financial Performance - In the quarter ending September 2025, CorVel achieved a 7% revenue growth to $240 million and a 15% increase in gross profit to $58.2 million [3] - The company is focused on sustaining its growth momentum through investments in workforce development via CorVel University [3] Technological Advancements - CorVel is advancing its AI-driven platforms, such as Care Edge, which provides real-time insights and automates routine tasks to enhance operational efficiency [4] - The company is leveraging emerging technologies, including Agentic AI, to improve efficiency, speed, and scalability in its operations [5] Company Overview - CorVel applies technology, including artificial intelligence and machine learning, to manage episodes of care and related healthcare costs, partnering with various stakeholders in the industry [6]

Revenue Growth - The Company's revenues increased to $239.6 million in the quarter ended September 30, 2025, from $224.4 million in the quarter ended September 30, 2024, an increase of $15.3 million, or 7%[86] - Revenue increased to $474.4 million for the six months ended September 30, 2025, up by $38.3 million or 9% from $436.1 million in the same period in 2024[104] - Patient management services revenues rose to $297.6 million, an increase of $11.2 million or 4%, while network solutions services revenues increased to $176.8 million, up by $27.0 million or 18%[104] Cost and Expenses - Cost of revenues increased to $181.5 million in the quarter ended September 30, 2025, from $173.6 million in the quarter ended September 30, 2024, an increase of $7.8 million, or 5%[87] - General and administrative expense increased to $22.3 million in the quarter ended September 30, 2025, from $22.1 million in the quarter ended September 30, 2024, an increase of $0.2 million, or 1%[88] - General and administrative expenses increased to $43.6 million, up by $1.4 million or 3%, accounting for approximately 9% of revenues[107] Profitability - Income before income tax provision increased to $35.9 million in the quarter ended September 30, 2025, from $28.7 million in the quarter ended September 30, 2024, an increase of $7.2 million, or 25%[89] - Net income increased to $27.9 million in the quarter ended September 30, 2025, from $23.4 million in the quarter ended September 30, 2024, an increase of $4.5 million, or 19.3%[95] - Gross profit increased to $58.2 million in the quarter ended September 30, 2025, from $50.7 million in the quarter ended September 30, 2024, an increase of $7.4 million, or 14.6%[95] - Income before income tax provision increased to $71.2 million, a rise of $14.5 million or 26% compared to $56.7 million in the same period in 2024[108] - Net income for the six months ended September 30, 2025, was $55.1 million, reflecting a 22.6% increase from $45.0 million in the prior year[103] - Gross profit for the six months ended September 30, 2025, was $114.8 million, representing a 16.1% increase from $98.9 million in the prior year[103] Cash Flow - Cash and cash equivalents increased to $207.5 million as of September 30, 2025, up by $36.9 million from $170.6 million as of March 31, 2025[110] - Net cash provided by operating activities rose to $80.0 million, an increase of $17.3 million from $62.7 million in the same period in 2024[114] Taxation - The effective tax rate was 22% for the quarter ended September 30, 2025, compared to 18% for the quarter ended September 30, 2024[89] - The effective tax rate for the six months ended September 30, 2025, was 23%, compared to 21% for the same period in 2024[108] Acquisitions - The Company acquired a privately held technology firm during the quarter ended September 30, 2025, enhancing its bill review process[85] Future Expectations - The company expects general and administrative expenses to remain at approximately 9% to 11% of revenues in future quarters[1]

Core Points - CorVel Corporation is conducting a quarterly earnings release webcast to discuss its financial performance and future projections [1] - The company emphasizes that any forward-looking statements made during the webcast are predictions and actual results may differ materially [1] Company Information - Michael Combs serves as the President and Chief Executive Officer of CorVel Corporation [2]

Financial Data and Key Metrics Changes - Revenues for the September quarter were $240 million, a 7% increase from $224 million in the same quarter of the previous year [5] - Earnings per share (EPS) for the quarter were $0.54, a 20% increase from $0.45 in the same quarter of the prior year, adjusted for a 3-for-1 stock split [5] - The combined effect of one-time events in the September quarter softened the increase in EPS by approximately 9 percentage points [5] - Gross margin and net income reached $28 million, up from $23 million in the previous year [18] - The company repurchased 143,774 shares at a cost of $12.8 million during the quarter, totaling 114.7 million shares repurchased for $854 million since inception [19] Business Line Data and Key Metrics Changes - Patient management services generated approximately $4 million in revenue growth [18] - Network solutions increased by $12 million, primarily due to higher utilization of ancillary care and bill review solutions [18] - The service division is innovating under increasing pricing pressure, focusing on delivering savings and operational efficiencies [13] Market Data and Key Metrics Changes - The workers' compensation labor market is facing a demographic shift, losing experienced professionals faster than new ones are being attracted [9] - The commercial health segment is experiencing elevated pricing pressure, necessitating a focus on savings and operational efficiencies [8] Company Strategy and Development Direction - The company is investing in workforce development through CorVel University to address industry-wide labor challenges [10] - Leveraging agentic AI to enhance productivity, reduce costs, and accelerate decision-making across the enterprise [10][12] - Focus on expanding business with existing partners and enhancing technological expertise through mergers and acquisitions [18] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges in the labor market but sees opportunities in workforce development and technological innovation [9][10] - The commitment to responsible AI principles remains unchanged, emphasizing human expertise directing AI [12] - The company is positioned well for continued product expansion and acquisition opportunities due to a strong and debt-free balance sheet [20] Other Important Information - The company is enhancing claims accuracy and efficiency through new digital communication platforms and AI integration [14][15] - Ongoing product enhancements and strong operational management have generated lower direct costs, allowing revenue growth to outpace expenses [19] Q&A Session Summary - The Q&A session was not detailed in the provided content, and thus no specific questions and answers are available for summary.

Financial Data and Key Metrics Changes - The September quarter revenues were $240 million, a 7% increase from $224 million in the September 2024 quarter [5] - Earnings per share for the quarter ending September 30, 2025, were $0.54, a 20% increase over the prior year's EPS of $0.45 [5] - The combined effect of one-time events in the September quarter softened the increase in EPS by approximately 9 percentage points [5] - Gross margin and net income reached $28 million, up from $23 million in the previous year [18] - The company repurchased 143,774 shares at a cost of $12.8 million during the quarter, totaling 114.7 million shares repurchased for $854 million since inception [19] Business Line Data and Key Metrics Changes - Patient management services generated approximately $4 million in revenue growth [18] - Network solutions increased by $12 million, primarily due to higher utilization of ancillary care and bill review solutions [18] - Recent AI-driven enhancements improved capacity and precision in identifying medical bills and claims with potential savings [13] Market Data and Key Metrics Changes - The workers' compensation field is experiencing a demographic shift, losing experienced professionals faster than attracting replacements [9] - The commercial health segment is facing elevated pricing pressure, necessitating a focus on delivering savings and operational efficiencies [8] Company Strategy and Development Direction - The company is investing in people through CorVel University to address workforce challenges and build the next generation of experts [10] - Leveraging agentic AI to enhance productivity, reduce costs, and accelerate decision-making across the enterprise [10][12] - The focus on expanding the suite of offerings to current partners and enhancing technological expertise through mergers and acquisitions [18] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges in the workers' compensation labor market and the commercial health pricing pressure but sees opportunities in these challenges [8][9] - The commitment to responsible AI principles remains unchanged, focusing on human expertise directing AI [12] - The company is positioned well for continued product expansion and acquisition opportunities due to a strong and debt-free balance sheet [20] Other Important Information - The company’s day sales outstanding improved to 40 days, an improvement of two days compared to the same period a year ago [19] - The quarter-ending cash balance was $207 million [19] Q&A Session Summary - The Q&A session was opened for questions but concluded without any specific inquiries or responses being documented [21][22]

Financial Data and Key Metrics Changes - Revenues for the September quarter were $240 million, a 7% increase from $224 million in the same quarter of the previous year [5] - Earnings per share (EPS) for the quarter were $0.54, reflecting a 20% increase from $0.45 in the prior year [5] - The combined effect of one-time events softened the increase in EPS by approximately 9 percentage points [5] - Gross margin and net income reached $28 million, up from $23 million in the previous year [18] - The company repurchased 143,774 shares at a cost of $12.8 million during the quarter, totaling 69% of the total shares outstanding repurchased to date [19][20] Business Line Data and Key Metrics Changes - Patient management services generated approximately $4 million in revenue growth [18] - Network solutions increased by $12 million, primarily due to higher utilization of ancillary care and bill review solutions [18] - The service division is innovating under increased pricing pressure, focusing on delivering savings and operational efficiencies [13] Market Data and Key Metrics Changes - The workers' compensation labor market is facing a demographic shift, losing experienced professionals faster than new ones can be recruited [9] - The commercial health segment is experiencing elevated pricing pressure, necessitating a focus on savings and operational efficiencies [7] Company Strategy and Development Direction - The company is investing in workforce development through CorVel University to address industry-wide labor challenges [10] - Leveraging agentic AI to enhance productivity, reduce costs, and accelerate decision-making across the enterprise [10][12] - The focus on mergers and acquisitions aims to expand the suite of offerings to current partners and enhance technological expertise [18] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges in the labor market but sees opportunities in workforce development and technological innovation [9][10] - The commitment to responsible AI principles remains unchanged, focusing on human expertise directing AI [12] - The company is positioned well for continued product expansion and acquisition opportunities due to a strong and debt-free balance sheet [20] Other Important Information - The company is enhancing claims accuracy and efficiency through new digital communication platforms and AI-powered tools [14][15] - Ongoing product enhancements and strong operational management have led to lower direct costs, allowing revenue growth to outpace expenses [19] Q&A Session Summary - The Q&A session was opened for questions but concluded without specific inquiries being documented [21]

Financial Performance - Revenues for the quarter ended September 30, 2025, were $240 million, a 7% increase from $224 million in the same quarter of 2024[1] - Earnings per share for the quarter were $0.54, up 20% from $0.45 in the same quarter of the prior year[1] - Gross profit increased 15% to $58.2 million, with a gross margin of 24% compared to $50.7 million in the same quarter of fiscal year 2025[6] - For the six months ended September 30, 2025, revenues were $474 million, a 9% increase from $436 million during the same period in 2024[1] - Net income for the quarter was $27.9 million, compared to $23.4 million in the same quarter of the prior year[8] Cash and Assets - The company exited the quarter with $207 million in cash and cash equivalents, with no borrowings[6] - Total assets as of September 30, 2025, were $611.7 million, an increase from $546.0 million as of March 31, 2025[9] Strategic Initiatives - CorVel is addressing workforce challenges by developing new talent through CorVel U, enhancing retention and service quality[3] - The company is leveraging Agentic AI to improve efficiency and scalability across operations, automating complex processes[4] Shareholder Actions - CorVel repurchased $12.8 million of common stock during the quarter[6]

Core Insights - CorVel Corporation will host a live webcast on November 4, 2025, at 11:30 AM Eastern Time to discuss its upcoming quarterly earnings results and introduce its new Chief Financial Officer, Brian Nichols [1][2]. Financial Performance and Strategic Initiatives - The webcast will include discussions on CorVel's financial performance, strategic initiatives, and future outlook, led by President and CEO Michael Combs and CFO Brian Nichols [2]. Webcast Details - Investors, analysts, and interested parties are encouraged to join the webcast for insights into CorVel's performance, with a dedicated question-and-answer session available for attendees [3][6].

Core Insights - The health care sector is experiencing a trend of oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Group 1: Oversold Stocks - MoonLake Immunotherapeutics (NASDAQ: MLTX) has an RSI of 21.5, with a stock price drop of approximately 86% over the past month, reaching a 52-week low of $5.95. The stock saw a 13% increase to close at $8.43 [3][7] - CorVel Corp (NASDAQ: CRVL) has an RSI of 27.2, with a stock price decline of around 14% over the past month, hitting a 52-week low of $72.15. The stock rose 0.6% to close at $73.83 [4][7] - Harmony Biosciences Holdings Inc (NASDAQ: HRMY) has an RSI of 28.9, with a stock price decrease of about 24% over the past month, reaching a 52-week low of $26.26. The stock gained 2% to close at $27.28 [4][7] Group 2: Company Updates - MoonLake Immunotherapeutics reported week-16 results from its Phase 3 VELA-1 and VELA-2 trials, using HiSCR75 as the primary endpoint [7] - CorVel's CFO Brandon T. O'Brien stepped down, impacting the company's stock performance [7] - Harmony Biosciences Holdings announced topline results from its Phase 3 RECONNECT Study for ZYN002 in Fragile X syndrome, highlighting a catalyst-rich pipeline and plans for future trials [7]